- Home
- IMXI vs TRML Comparison
IMXI vs TRML Comparison
Compare IMXI & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- TRML
- Stock Information
- Founded
- IMXI 1994
- TRML 2021
- Country
- IMXI United States
- TRML United States
- Employees
- IMXI N/A
- TRML N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- IMXI Technology
- TRML Health Care
- Exchange
- IMXI Nasdaq
- TRML Nasdaq
- Market Cap
- IMXI 559.5M
- TRML 509.8M
- IPO Year
- IMXI N/A
- TRML N/A
- Fundamental
- Price
- IMXI $13.02
- TRML $13.40
- Analyst Decision
- IMXI Buy
- TRML Strong Buy
- Analyst Count
- IMXI 7
- TRML 6
- Target Price
- IMXI $24.40
- TRML $45.20
- AVG Volume (30 Days)
- IMXI 370.9K
- TRML 378.2K
- Earning Date
- IMXI 05-07-2025
- TRML 05-12-2025
- Dividend Yield
- IMXI N/A
- TRML N/A
- EPS Growth
- IMXI 9.82
- TRML N/A
- EPS
- IMXI 1.79
- TRML N/A
- Revenue
- IMXI $658,649,000.00
- TRML N/A
- Revenue This Year
- IMXI $2.83
- TRML $363.93
- Revenue Next Year
- IMXI $4.36
- TRML N/A
- P/E Ratio
- IMXI $7.14
- TRML N/A
- Revenue Growth
- IMXI N/A
- TRML N/A
- 52 Week Low
- IMXI $12.42
- TRML $11.87
- 52 Week High
- IMXI $23.02
- TRML $29.79
- Technical
- Relative Strength Index (RSI)
- IMXI 34.37
- TRML 35.48
- Support Level
- IMXI $12.42
- TRML $16.39
- Resistance Level
- IMXI $13.73
- TRML $17.36
- Average True Range (ATR)
- IMXI 0.37
- TRML 1.09
- MACD
- IMXI 0.15
- TRML -0.38
- Stochastic Oscillator
- IMXI 45.98
- TRML 6.36
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.